Bell Potter revised their price target down to $1.40 from $2 because
* Higher rate for DCF
* Less revenue expected in 24 or 25
* Pharma tech is being sold off
google "bell potter PAR $1.40" and look for a video towards the end. It doesn't say much more than the 3 bullet points.
What they didn't say was there is another CR coming in 1q 2024 which they hope to be in again, and that there will be more expense chasing TGA etc.
Anyway, i bought some more yesterday. That's enough for me until the CR.
IMO. DYOR.
Bell Potter revised their price target down to $1.40 from $2...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.030(10.9%) |
Mkt cap ! $85.7M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 27.5¢ | 24.0¢ | $429.9K | 1.713M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 161991 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 29634 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
25.0¢ |
Change
-0.030 ( 7.51 %) |
||||
| Open | High | Low | Volume | ||
| 27.0¢ | 27.0¢ | 23.5¢ | 433775 | ||
| Last updated 15.57pm 03/05/2024 ? | |||||
| PAR (ASX) Chart |